What is the effect of adding teriparatide or abaloparatide to alendronate therapy in patients with osteoporosis?
Year: 2026
Type: article
Abstract: Evidence from high-quality studies demonstrates that sequential therapy with abaloparatide or teriparatide followed by alendronate increases bone density and reduces fracture risk in patients with osteoporosis, compared to placebo followed by alendronate.
Author: Tripdatabase
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225920167
